In the March 2024 issue of Hepatology Communications in the article by Hu et al., “Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD)”, funding information was inadvertently left out. Please note this work was supported by Natural Science Foundation of China under Grant NO.82302586 and The Voyage Project of The Second Xiangya Hospital of Central South University.
REFERENCE
- 1. Long Q, Luo F, Li B, Li Z, Guo Z, Chen Z, et al. Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease. Hepatology Communications. 2024;8:e0310. [DOI] [PMC free article] [PubMed] [Google Scholar]